Literature DB >> 33168659

Computed tomography-based triage of extensive baseline infarction: ASPECTS and collaterals versus perfusion imaging for outcome prediction.

Rosalie McDonough1, Sarah Elsayed2, Tobias Djamsched Faizy3, Friederike Austein2, Peter B Sporns4, Lukas Meyer2, Matthias Bechstein2, Noel van Horn2, Marie Teresa Nawka2, Gerhard Schön5, Helge Kniep2, Uta Hanning2, Jens Fiehler2, Jeremy J Heit6, Gabriel Broocks2.   

Abstract

BACKGROUND: Patients presenting with large baseline infarctions are often excluded from mechanical thrombectomy (MT) due to uncertainty surrounding its effect on outcome. We hypothesized that computed tomography perfusion (CTP)-based selection may be predictive of functional outcome in low Alberta Stroke Program Early CT Score (ASPECTS) patients.
METHODS: This was a double-center, retrospective analysis of patients presenting with ASPECTS≤5 who received multimodal admission CT imaging between May 2015 and June 2020. The predicted ischemic core (pCore) was defined as a reduction in cerebral blood flow (rCBF), while mismatch volume was defined using time to maximum (Tmax). The pCore perfusion mismatch ratio (CPMR) was also calculated. These parameters (pCore, mismatch volume, and CPMR), as well as a combined radiological score consisting of ASPECTS and collateral status (ASCO score), were tested in logistic regression and receiver operating characteristic (ROC) analyses. The primary outcome was favorable modified Rankin Scale (mRS) at discharge (≤3).
RESULTS: A total of 113 patients met the inclusion criteria. The median ischemic core volume was 74.1 mL (IQR 43.8-121.8). The ASCO score was associated with favorable outcome at discharge (aOR 3.7, 95% CI 1.8 to 10.7, P=0.002), while no association was observed for the CTP parameters. A model including the ASCO score also had significantly higher area under the curve (AUC) values compared with the CTP-based model (0.88 vs 0.64, P=0.018).
CONCLUSIONS: The ASCO score was superior to the CTP-based model for the prediction of good functional outcome and could represent a quick, practical, and easily implemented method for the selection of low ASPECTS patients most likely benefit from MT. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  CT; CT perfusion; intervention; stroke; thrombectomy

Year:  2020        PMID: 33168659     DOI: 10.1136/neurintsurg-2020-016848

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

1.  Venous Outflow Profiles Are Linked to Clinical Outcomes in Ischemic Stroke Patients with Extensive Baseline Infarct.

Authors:  Laurens Winkelmeier; Gabriel Broocks; Helge Kniep; Vincent Geest; Jonathan Reinwald; Lukas Meyer; Noel van Horn; Adrien Guenego; Kamil Zeleňák; Gregory W Albers; Maarten Lansberg; Peter Sporns; Max Wintermark; Jens Fiehler; Jeremy J Heit; Tobias D Faizy
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

2.  Editorial comment: new imaging score for outcome prediction in basilar artery occlusion stroke.

Authors:  Michalis Mantatzis
Journal:  Eur Radiol       Date:  2022-05-30       Impact factor: 7.034

3.  Relationship between the degree of recanalization and functional outcome in acute ischemic stroke is mediated by penumbra salvage volume.

Authors:  Gabriel Broocks; Hashim Jafarov; Rosalie McDonough; Friederike Austein; Lukas Meyer; Matthias Bechstein; Noel van Horn; Marie Teresa Nawka; Gerhard Schön; Jens Fiehler; Helge Kniep; Uta Hanning
Journal:  J Neurol       Date:  2021-01-24       Impact factor: 4.849

4.  The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray-What Current Trials May Have Missed.

Authors:  Gabriel Broocks; Lukas Meyer; Rosalie McDonough; Matthias Bechstein; Uta Hanning; Jens Fiehler; Andre Kemmling
Journal:  Front Neurol       Date:  2022-01-14       Impact factor: 4.003

5.  Editorial: Mechanisms, Measurement, and Management of Vasogenic Edema After Stroke.

Authors:  Gabriel Broocks; Jens Minnerup; Shervin Kamalian; Andre Kemmling
Journal:  Front Neurol       Date:  2022-02-24       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.